| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 2035 |
| 1 | LETROZOLE TABLETS | 1712 |
| 2 | FULVESTRANT | 1696 |
| 3 | ESTROGENS, CONJUGATED | 1682 |
| 4 | CONJUGATED ESTROGENS | 1680 |
| 5 | RIBOCICLIB | 1678 |
| 6 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 1505 |
| 7 | MEDROXYPROGESTERONE ACETATE | 1384 |
| 8 | CAPECITABINE | 1248 |
| 9 | PALBOCICLIB | 1077 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 1505 | 0.0641 |
| 1 | RIBOCICLIB | 1678 | 0.0513 |
| 2 | FULVESTRANT | 1696 | 0.0506 |
| 3 | EXEMESTANE | 849 | 0.0395 |
| 4 | VINORELBINE | 249 | 0.0357 |
| 5 | LETROZOLE TABLETS | 1712 | 0.0350 |
| 6 | LETROZOLE | 2035 | 0.0326 |
| 7 | NERATINIB | 71 | 0.0306 |
| 8 | CONJUGATED ESTROGENS | 1680 | 0.0289 |
| 9 | ESTROGENS, CONJUGATED | 1682 | 0.0284 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 2855 |
| 1 | Estrogen [EPC] | 2165 |
| 2 | Kinase Inhibitor [EPC] | 1878 |
| 3 | Estrogen Receptor Antagonist [EPC] | 1706 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1353 |
| 5 | Microtubule Inhibitor [EPC] | 1121 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 1072 |
| 7 | RANK Ligand Inhibitor [EPC] | 829 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 730 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 496 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 1706 | 0.0421 |
| 1 | Farnesyltransferase Inhibitor [EPC] | 2 | 0.0256 |
| 2 | Aromatase Inhibitor [EPC] | 2855 | 0.0251 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 1072 | 0.0143 |
| 4 | Estrogen [EPC] | 2165 | 0.0116 |
| 5 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 6 | Endoglycosidase [EPC] | 15 | 0.0081 |
| 7 | Provitamin D2 Compound [EPC] | 215 | 0.0072 |
| 8 | Microtubule Inhibitor [EPC] | 1121 | 0.0068 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1353 | 0.0049 |